Two Sigma Investments’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-58,829
Closed -$319K 3929
2025
Q2
$319K Buy
58,829
+10,800
+22% +$53.9K ﹤0.01% 2767
2025
Q1
$167K Buy
+48,029
New +$233K ﹤0.01% 2887
2024
Q2
Sell
-23,848
Closed -$225K 3331
2024
Q1
$225K Buy
+23,848
New +$232K ﹤0.01% 2668
2022
Q4
Sell
-25,000
Closed -$474K 3081
2022
Q3
$474K Buy
+25,000
New +$451K ﹤0.01% 1802

Other funds holding THRD

Two Sigma Investments's THRD Position: Q3 2025 in Review

Two Sigma Investments sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 58,829 shares — an estimated $319K sold.

Two Sigma Investments first reported a position in THRD in Q3 2022 and held it in 4 quarters. The position peaked at $474K in Q3 2022. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Two Sigma Investments reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 58,829 Third Harmonic Bio shares in Q3 2025, an estimated $319K.
  • Two Sigma Investments first reported a position in Third Harmonic Bio in Q3 2022 and held it in 4 quarters.
  • Two Sigma Investments's Third Harmonic Bio position peaked at $474K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.